-A Besarab Researcher Activity Profile

Research Author Detailed Information 

A Besarab Publication Rate By Year

A Besarab has published 1 paper(s) in 1986, 1 paper(s) in 1998, 14 paper(s) in 2007, 3 paper(s) in 2008, for a total of 19 research publications in total.

A A Besarab Author Information

LAST NAME: besarab

FIRST NAME: A

INITIALS: a

AFFILIATION:

Papers

A Besarab's Publication Record

1. The native arteriovenous fistula in 2007. Surveillance and monitoring. Year Published: 2007
Division of Nephrology and Hypertension, Henry Ford Health System, Detroit, Michigan - USA.
2. The native arteriovenous fistula in 2007. Research needs. Year Published: 2007
Division of Nephrology and Hypertension, Henry Ford Health System, Detroit, Michigan - USA.
3. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. Year Published: 1998
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, USA.
4. The native arteriovenous fistula in 2007. Surveillance and monitoring. Year Published: 2007
Department of Medicine, Henry Ford Health System, Detroit, Michigan, USA. abesara1@hfhs.org
5. The native arteriovenous fistula in 2007. Research needs. Year Published: 2007
Department of Medicine, Henry Ford Health System, Detroit, Michigan ,USA. abesara1@hfhs.org
6. Intracranial calcification in adults with chronic lead exposure. Year Published: 1986
7. Clinical epidemiology of arteriovenous fistula in 2007. Year Published: 2007
Clinical Epidemiology Unit, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. Pietro.Ravani@med.mun.ca
8. Autogenous arteriovenous fistula options. Year Published: 2007
Dialysis Management Medical Group, San Francisco, California 94109, USA. vampdoc@aol.com
9. Vascular mapping techniques: advantages and disadvantages. Year Published: 2007
Division of Nephrology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida 3136, USA. Aasif@med.miami.edu
10. Surgical salvage of the autogenous arteriovenous fistula (AVF). Year Published: 2007
Dialysis Management Medical Group, San Francisco, CA 94109, USA. vampdoc@aol.com
11. Interventional nephrology: from episodic to coordinated vascular access care. Year Published: 2007
Division of Nephrology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. aasif@med.miami.edu
12. Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. Year Published: 2007
Division of Nephrology, Department of Medicine, Winthrop-University Hospital, Mineola, New York, USA. sfishbane@metrorenal.com
13. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. Year Published: 2007
Department of Nephrology and Transplantation Medicine, Medical University, Wroclaw, Poland. klinger@wp.pl
14. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. Year Published: 2007
Department of Nephrology and Transplantation Medicine, Medical University, Wroclaw, Poland. klinger@wp.pl
15. Surgical salvage of the autogenous arteriovenous fistula (AVF). Year Published: 2007
Dialysis Management Medical Group, San Francisco, CA 94109, USA. vampdoc@aol.com
16. Interventional nephrology: from episodic to coordinated vascular access care. Year Published: 2007
Division of Nephrology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. aasif@med.miami.edu
17. The normal hematocrit study--follow-up. Year Published: 2008
18. The normal hematocrit study--follow-up. Year Published: 2008
19. New developments in anemia management in chronic kidney disease. Year Published: 2008
Beth Israel Medical Center NewYork, NewYork, USA.